Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Assurance Vs. Flexibility: Unit-Of-Use Packaging Offers Trade-Offs For Patient Leaflets

Executive Summary

Manufacturers would have full responsibility for writing, producing, and ultimately delivering the new patient medication information document with their products, if FDA decides the industry should fully adopt the unit-of-use packaging.
Advertisement

Related Content

Acting US FDA Chief Scientist Tapped, As Borio Moves To White House Biodefense Detail
Chief Scientist At US FDA Is Hinton As Borio Moves To White House
E-Submission Part Of FDA Reg Reform Plan; Alzheimer’s Data Standard About To Debut
E-Submission Part Of FDA Reg Reform Plan; Alzheimer’s Data Standard About To Debut
Should Rx Patient Leaflets Be Labeled Like Dietary Supplements?
FDA Must Maintain Oversight Role In PMI Development, Groups Urge

Topics

Advertisement
UsernamePublicRestriction

Register

PS052661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel